Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by FactFinder1994on Oct 29, 2020 7:18pm
182 Views
Post# 31810392

RE:RE:People not seeing the big picture

RE:RE:People not seeing the big pictureIndeed Barry - think precision medicine.  (detect, measure and GUIDE therapies)
SQI's serology test will be able to be used to quantify antibodies at a nanoparticle level, and therefore will be of use only days after infection....making it a valuable test in determining not only that someone HAD Covid, but also if they currently HAVE Covid?

I would like to suggest there may be some updates to prevailing or traditional experience and thinking. 

Standard serology tests have typically had to be taken at least a couple weeks after initial infection in order for there to be enough antibodies to be detected.  We will be learning more about SQI's technology very soon, but look for technology that will be able to detect antibodies after only days!   This will be a huge benefit, as this antibody test will be able to quantify the level of antibodies from the smallest levels to the largest.  This is why when Rob joined the company, there has been a subtle change to SQI, in calling it a precision medicine company.....they have yet to promote this aspect.  
 
Now think a little bigger (or a lot!!).....A Covid Serology test that not only detects antibodies, but quantifies them in nanoparticles.  Why use an old antigen test to detect the virus (and they haven't worked all that well anyway), and also why use a non-specific serology test?  A highly sensitive serology antibody test replaces both of these old tests given its ability to pick up antibodies only days after initial infection (that is huge).  Being able to determine specific levels of antibodies is also important in determining when a vaccination or re-vaccination is required.  This will be huge for SQI Diagnostics (SQD).
 
The benefits in a test of this nature are massive....
 
Stay tuned,  
<< Previous
Bullboard Posts
Next >>